• 无工作经验
  • 招若干人
  • 11-09 发布

职位描述

职位描述: Professional skills:Lead study design, protocol development and execution of clinical studies in early (Ph1 and Ph2a) phases in Asia/China, to support global, Asia and China compound/new-indication early development and China registration as well.Acts as an early clinicial representitive to participate on cross functional teams for evaluation of new product ideas, implementation of business strategies, and so on.Acts as early China compound lead, to develop and drive the goals and activities of cross functions in both China/Asia and global team, to develop and timely update a comprehensive development plan for compound in early stage, align with key stakeholders to move the project forward.Performs full support to the pre-clinical patient related Ph0 studies by working closely with the scientific project lead.Provides technical expertise to formulate early clinical development plan and make sure it is consistent with the overall clinical development plan.Be a study responsible physician or/and an early clinical lead to responsible for managing study plan as well involves into managing and monitoring daily activities of early clinical studies/projects.Involved into managing project budgets and projections for early clinical project.Monitors and reports clinical findings to senior management. Evaluates/interprets results of phase 1/ph2a investigations and in preparation for evaluation to next-step new drug development, report to senior management and health authority etc.Be responsible for the compliance of ED, company and regulatory standards and procedures. And ensures that all activities are in compliance with department safety practices, policies and procedures.Applies scientific discipline to minimize risk and increase performance.Requirements1. MD training and with 2-5 years clinical practice is mandatory. PhD training is plus.2. Around 3-7 years’ experience clinical development in industry, with early clinical development experience is plus.3. Oncology or immunology background is preferred.4. Excellent Chinese/English speaking and writing. 职能类别: 医药技术研发管理人员

联系方式

虹桥路355号城开国际大厦

公司信息

公司简介(中文) 恢复为 “成立于1985年的西安杨森制药有限公司(“西安杨森”)是中国最大的合资制药企业之一,也是中国改革开放以来进入中国的最早一批制药公司之一,其总部位于北京的中央商业区。西安杨森是强生公司的一员。从创立之初,西安杨森就致力于引进和生产许多创新产品和高质量产品。西安杨森一直致力于投资未来,计划增加在生物制品、心脏病学、风湿病学和泌尿科学领域的新系列产品。西安杨森致力于利用这些新药改善中国患者的医疗保健状况。 本着公司信条和关爱精神,西安杨森一直是活跃的企业公民,在医药、公共卫生、药物研发领域和企业社会责任方面从事了五十多项合作项目。例如,西安杨森与中国卫生部国际卫生交流与合作中心合作创立了“吴阶平医学研究奖和保罗•杨森药学研究奖”,旨在鼓励医药学领域的工作者不断创新。在过去的17年中,共计305名杰出医药学工作者在45个专业领域获得了该奖项,他们在科研领域做出了大量有价值的创新。 此外,西安杨森也被誉为培养制药行业人才的摇篮。1999年,西安杨森被财富杂志(中文版)评选为“中国最受敬仰的十大外资企业之一”。2005年,西安杨森被中国中央电视台评选为“***雇主”,并且分别在2008年、2009年和2010年获得了“中国大学生***雇主奖”。 目前西安杨森所有的招聘信息仅通过前程无忧,智联招聘和猎聘网进行发布,任何在非上述三家招聘网站看到的信息均非西安杨森正式发布。为避免对您的合法权益造成伤害,请务必通过正规渠道投递简历。 2013年,强生在西安高新区投资兴建强生全球供应链先进的生产基地,该项目建设目前已正式启动。新生产基地占地267,000平方米,将取代西安杨森在西安新城区现有的生产基地,成为强生供应链在亚洲的创新枢纽,从而更好地满足中国和其他新兴市场不断增长的需求。新的生产基地将采用世界***的制造技术和先进的质量体系,并引进集电子批号记录和数据存储于一身的全自动化配方生产操作系统以及先进的德国进口生产工艺设备。

猎才二维码